neither abnormal laboratory data nor adverse events are related to the test drug in the 600 patients who received the test drug. This is consistent with the findings obtained in Japan.

past or current treatment with anti-H. pylori therapy; or (viii) severe systemic diseases. Prior to inclusion in the study, informed consent was obtained from all patients. The protocol of this ...

pylori infection, according to Dr Vatsya: Urea breath test in which patients ... A stool antigen test is performed to detect the occurrence of H. pylori proteins in faeces. Blood tests can also ...